Literature DB >> 378753

Substance P-, VIP-, and enkephalin-like immunoreactivity in the human vagus nerve.

J M Lundberg, T Hökfelt, J Kewenter, G Pettersson, H Ahlman, R Edin, A Dahlström, G Nilsson, L Terenius, K Uvnäs-Wallensten, S Said.   

Abstract

The human vagus nerve has been investigated for the presence of substance P (SP), vasoactive intestinal polypeptide (VIP), and enkephalin (ENK) using immunohistochemistry. After 0.5-4 hr of nerve ligation during surgical operations two right thoracic main truncs, two anterior subdiaphragmal trunks, and four anterior nerves of Latarjet were found to contain accumulation of immunoreactive material in nerve fibers above the ligation. Very high numbers of SP-, medium numbers of ENK-, and low number of VIP-immunoreactive fibers were seen. The relative proportions were similar at all levels studied. These data thus indicate the presence and axonal transport of SP-, ENK-, and VIP-like peptides in the human vagus nerve. Our observations in humans correlate well with results obtained from other species. Thus gastrointestinal vagal sensory mechanisms may be mediated by SP (and possibly VIP) and some motor mechanisms by ENK.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 378753

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  34 in total

1.  Effects of naloxone and opioid agonists on gastric excitatory responses to stimulation of the vagus nerve in cats.

Authors:  T Okamoto; K Kurahashi; M Fujiwara
Journal:  Br J Pharmacol       Date:  1988-10       Impact factor: 8.739

2.  Intramural distribution of immunoreactive vasoactive intestinal polypeptide (VIP), substance P, somatostatin and mammalian bombesin in the oesophago-gastro-pyloric region of the human gut.

Authors:  G L Ferri; T E Adrian; L Soimero; M Blank; D Cavalli; G Biliotti; J M Polak; S R Bloom
Journal:  Cell Tissue Res       Date:  1989-04       Impact factor: 5.249

3.  Peptides in metabolic autonomic nerves.

Authors:  K Uvnäs-Wallensten
Journal:  Diabetologia       Date:  1981-03       Impact factor: 10.122

4.  VIP like immunoreactive nerves in human respiratory tract. Light and electron microscopic study.

Authors:  A Laitinen; M Partanen; A Hervonen; M Pelto-Huikko; L A Laitinen
Journal:  Histochemistry       Date:  1985

5.  Neuronally released vasoactive intestinal polypeptide alters atrial electrophysiological properties and may promote atrial fibrillation.

Authors:  Yutao Xi; Zhi-Yang James Chao; Wen Yan; Shahrzad Abbasi; Xiaomeng Yin; Nilesh Mathuria; Mehul Patel; Christopher Fan; Junping Sun; Geru Wu; Suwei Wang; MacArthur Elayda; Lianjun Gao; Xander H T Wehrens; Shien-Fong Lin; Jie Cheng
Journal:  Heart Rhythm       Date:  2015-03-05       Impact factor: 6.343

6.  Evidence for non-cholinergic, non-adrenergic nervous control of mucus secretion into the cat trachea.

Authors:  A C Peatfield; P S Richardson
Journal:  J Physiol       Date:  1983-09       Impact factor: 5.182

7.  Secretin and VIP-stimulated adenylate cyclase from rat heart. II. Impairment in spontaneous hypertension.

Authors:  P Chatelain; P Robberecht; P De Neef; J C Camus; D Heuse; J Christophe
Journal:  Pflugers Arch       Date:  1980-12       Impact factor: 3.657

8.  Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation.

Authors:  P Chatelain; P Robberecht; P De Neef; M Deschodt-Lanckman; W König; J Christophe
Journal:  Pflugers Arch       Date:  1980-12       Impact factor: 3.657

9.  Peptide-containing neurons intrinsic to the gut wall. An experimental study in the pig.

Authors:  G Malmfors; S Leander; E Brodin; R Håkanson; T Holmin; F Sundler
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

10.  VIP (vasoactive intestinal polypeptide)--immunoreactive innervation of the portal vein.

Authors:  J Järhult; J Fahrenkrug; P Hellstrand; R Uddman
Journal:  Cell Tissue Res       Date:  1982       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.